Ion channels-related diseases

Acta Biochimica Polonica

Volumn 47, Issue 3, 2000, Pages 685-703

  Dworakowska, Beata ^a   Dołowy, Krzysztof ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

cGMP gated channel; Channel related genetic disorders; Glycine receptor; Ion channels; Nicotinic acetylcholine receptor; Voltage gated channels

Indexed keywords

ATAXIA;

CALCIUM CHANNEL; CFTR PROTEIN, HUMAN; CHLORIDE CHANNEL; GLYCINE RECEPTOR; ION CHANNEL; NICOTINIC RECEPTOR; POTASSIUM CHANNEL; SODIUM CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL; EPILEPSY; GENETICS; HEART DISEASE; HUMAN; MALIGNANT HYPERTHERMIA; METABOLIC DISORDER; METABOLISM; MUSCLE DISEASE; MUTATION; REVIEW;

ANIMALS; CALCIUM CHANNELS; CHLORIDE CHANNELS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPILEPSY; HEART DISEASES; HUMANS; ION CHANNELS; MALIGNANT HYPERTHERMIA; METABOLIC DISEASES; MUSCULAR DISEASES; MUTATION; POTASSIUM CHANNELS; RECEPTORS, GLYCINE; RECEPTORS, NICOTINIC; SODIUM CHANNELS;

EID: 0034570241     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.2000_3989     Document Type: Review

References (91)

1. Abbott, G.W., Sesti, F., Splawski, I., Buck, M.E., Lehmann, M.H., Timothy, K.W., Keating, M.T. & Goldstein, S.A. (1999) MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97, 175-187.
2. Adelman, J.P., Bond, C.T., Pessia, M. & Maylie, J. (1995) Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15, 1449-1454.
3. An, R.H., Wang, X.L., Kerem, B., Benhorin, J., Medina, A., Goldmit, M. & Kass, R.S. (1998) Novel LQT-3 mutation affects Na channel activity through interactions between alpha- and betal-subunits. Circular Res. 83, 141-146.
4. Bech-Hansen, N.T., Naylor, M.J., Maybaum, T.A., Pearce, W.G., Koop, B., Fishman, G.A., Mets, M., Musarella, M.A. & Boycott, K.M. (1998) Loss-of-function mutations in a calcium-channel alpha-1-subunit gene in Xp 11.23 cause incomplete X-linked congenital stationary night blindness. Nature Gen. 19, 264-267.
5. Bendahhou, S., Cummins, T.R., Kwiecinski, H., Waxman, S.G. & Ptacek, L.J. (1999a) Characterization of a new sodium channel mutation at arginine 1448 associated with moderate Paramyotonia congenita in humans. J. Physiol. (London) 518, 337-344.
6. Bendahhou, S., Cummins, T.R., Tawil, R., Waxman, S.G. & Ptacek, L.J. (1999b) Activation and inactivation of the voltage-gated sodium channel: Role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation. J. Neurosci. 19, 4762-4771.
7. Bennett, P.B., Yazawa, K., Makita, N. & George, A.L., Jr. (1995) Molecular mechanism for an inherited cardiac arrhythmia. Nature 376, 683-685.
8. + channel mutation causing both long-QT and Brugada syndromes. Circular Res. 85, 1206-1213.
9. Bianchi, L., Shen, Z., Dennis, A.T., Priori, S.G., Napolitano, C., Ronchetti, E., Bryskin, R., Schwartz, P.J. & Brown, A.M. (1999) Cellular dysfunction of LQT5-minK mutants: Abnormalities of IKs, IKr and trafficking in long QT syndrome. Hum. Mol. Gen. 8, 1499-1507.
10. Biervert, C., Schroeder, B.C., Kubisch, C., Berkovic, S.F., Propping, P., Jentsch, T.J. & Steinlein, O.K. (1998) A potassium channel mutation in neonatal human epilepsy. Science 279, 406-409.
11. Brunt, E.R & van Weerden, T.W. (1990) Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain 113, 1361-1382.
12. Bufler, J., Pitz, R., Czep, M., Wick, M. & Franke, C. (1998) Purified IgG from seropositive and seronegative patients with mysasthenia gravis reversibly blocks currents through nicotinic acetylcholine receptor channels. Ann. Neurol. 43, 458-464.
13. Chen, J., Zou, A., Splawski, I., Keating, M.T. & Sanguinetti, M.C. (1999) Long QT syndrome-associated mutations in the Per-Arnt-Sim , (PAS) domain of HERG potassium channels accelerate channel deactivation. J. Biol. Chem. 274, 10113-10118.
14. Chen, X.-Z., Vassilev, P.M., Basora, N., Peng, J.-B., Nomura, H., Segal, Y., Brown, E.M., Reeders, S.T., Hediger, M.A. & Zhou, J. (1999) Polycystin-L is a calcium-regulated cation channel permeable to calcium ions. Nature 401, 383-386.
15. Cheng, S.H., Gregory, R.J., Marshall, J., Paul, S., Souza, D.W., White, G.A., O'Riordan, C.R. & Smith, A.E. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63, 827-834.
16. + channel mutations in Romano-Ward and Jervell and Lange-Nielsen inherited cardiac arrhythmias. EMBO J. 16, 5472-5479.
17. Chouabe, C., Neyroud, N., Richard, P., Denjoy, I., Hainque, B., Romey, G., Drici, M.D., Guicheney, P. & Barhanin, J. (2000) Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk. Cardiovasc. Res. 45, 971-980.
18. D'Adamo, M.C., Imbrici, P., Sponcichetti, F. & Pessia, M. (1999) Mutations in the KCNA1 ' gene associated with episodic ataxia type-1 syndrome impair heteromeric voltage-gated K(+) channel function. FASEB J. 13, 1335-1345.
19. Dumaine, R., Towbin, J.A., Brugada, P., Vatta, M., Nesterenko, D.V., Nesterenko, V.V., Brugada, J., Brugada, R. & Antzelevitch, C. (1999) Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circular Res. 85, 803-809.
20. Engel, A.G., Lambert, E.H. & Howard, F.M. (1977) Immune complexes (IgG and C3) at the motor end-plate in my asthenia gravis: Ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin. Proc. 52, 267-280.
21. Engel, A.G., Ohno, K., Milone, M., Wang, H.L., Nakano, S., Bouzat, C., Pruitt, J.N. 2nd, Hutchinson, D.O., Brengman, J.M., Bren, N., Sieb, J.P. & Sine, S.M. (1996) New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum. Mol. Gen. 5, 1217-1227.
22. Escayg, A., De Waard, M., Lee, D.D., Bichet, D., Wolf, P., Mayer, T., Johnston, J., Baloh, R., Sander, T. & Meisler, M.H. (2000a) Coding and noncoding variation of the human calcium-channel beta(4)-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am. J. Hum. Gen. 66, 1531-1539.
23. Escayg, A., MacDonald, B.T., Meisler, M.H., Baulac, S., Huberfeld, G., An-Gourfinkel, I., Brice, A., LeGuern, E., Moulard, B., Chaigne, D., Buresi, C. & Malafosse, A. (2000b) Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nature Gen. 24, 343-345.
24. Fahlke, C., Beck, C.L. & George, A.L., Jr. (1997) A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel. Proc. Natl. Acad. Sci. U.S.A. 94, 2729-2734.
25. Featherstone, D.E., Fujimoto, E. & Ruben, P.C. (1998) A defect in skeletal muscle sodium channel deactivation exacerbates hyperexcitability in human paramyotonia congenita. J. Physiol. (London) 506, 627-638.
26. Franqueza, L., Lin, M., Splawski, I., Keating, M.T. & Sanguinetti, M.C. (1999) Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits. J. Biol. Chem. 274, 21063-21070.
27. Freedman, R., Hall, M., Adler, L.E. & Leonard, S. (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 38, 22-33.
28. George, A.L., Jr. (1998) Chloride channels and endocytosis: ClC-5 makes a dent. Proc. Natl. Acad. Sci. U.S.A. 95, 7843-7845.
29. Gomez, C.M., Maselli, R., Gundeck, J.E., Chao, M., Day, J.W., Tamamizu, S., Lasalde, J.A., McNamee, M. & Wollmann, R.L. (1997) Slow-channel transgenic mice: A model of postsynaptic organellar degeneration at the neuromuscular junction. J. Neurosci. 17, 4170-4179.
30. Green, D.S., George, A.L., Jr. & Cannon, S.C. (1998) Human sodium channel gating defects caused by missense mutations in S6 segments associated with myotonia: S804F and V1293I. J. Physiol. (London) 510, 685-694.
31. Gunther, W., Luchow, A., Cluzeaud, F., Vandewalle, A. & Jentsch, T.J. (1998) ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc. Natl. Acad. Sci. U.S.A. 95, 8075-8080.
32. Hans, M., Luvisetto, S., Williams, M.E., Spagnolo, M., Urrutia, A., Tottene, A., Brust, P.F., Johnson, E.C., Harpold, M.M., Stauderman, K.A. & Pietrobon, D. (1999) Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J. Neurosci. 19, 1610-1619.
33. Igarashi, T., Gunther, W., Sekine, T., Inatomi, J., Shiraga, H., Takahashi, S., Suzuki, J., Tsuru, N., Yanagihara, T., Shimazu, M., Jentsch, T.J. & Thakker, R.V. (1998) Functional characterization of renal chloride channel, CLCN5, mutations associated with Dent's Japan disease. Kidney Int. 54, 1850-1856.
34. Kambouris, N.G., Nuss, H.B., Johns, D.C., Tomaselli, G.F., Marban, E. & Balser, J.R. (1998) Phenotypic characterization of a novel long-QT syndrome mutation (R1623Q) in the cardiac sodium channel. Circulation 97, 640-644.
35. Karolyi, L., Koch, M.C., Grzeschlik, K.-H. & Seyberth, H.W. (1998) The molecular genetic approach to "Bartter's syndrome". J. Mol. Med. 76, 317-325.
36. Kohl, S., Marx, T., Giddings, I., Jagle, H., Jacobson, S.G., Apfelstedt-Sylla, E., Zrenner, E., Sharpe, L.T. & Wissinger, B. (1998) Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel. Nature Gen. 19, 257-259.
37. 2+ channel kinetics. J. Biol. Chem. 273, 5586-5590.
38. Kubisch, C., Schmidt-Rose, T., Fontaine, B., Bretag, A.H. & Jentsch, T.J. (1998) ClC-1 chloride channel mutations in myotonia congenita: Variable penetrance of mutations shifting the voltage dependence. Hum. Mol. Gen. 7, 1753-1760.
39. Kubisch, C., Schroeder, B.C., Friedrich, T., Lutjohann, B., El-Amraoui, A., Marlin, S., Petit, C. & Jentsch, T.J. (1999) KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96, 437-446.
40. 2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. J. Neurosci. 17, 9035-9047.
41. Lees-Miller, J.P., Duan, Y., Teng, G.Q., Thorstad, K. & Duff, H.J. (2000) Novel gain-of-function mechanism in K(+) channel-related long-QT syndrome: Altered gating and selectivity in the HERG1 N629D mutant. Circular Res. 86, 507-513.
42. Leonard, S., Adams, C., Breese, C.R., Adler, L.E., Bickford, P., Byerley, W., Coon, H., Griffith, J.M., Miller, C., Myles-Worsley, M., Nagamoto, H.T., Rollins, Y., Stevens, K.E., Waldo, M. & Freedman, R. (1996) Nicotinic receptor function in schizophrenia. Schizophr. Bull. 22, 431-445.
43. + current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann. Neurol. 46, 305-312.
44. Lewis, T.M., Sivilotti, L.G., Colquhoun, D., Gardiner, R.M., Schoepfer, R. & Rees, M. (1998) Properties of human glycine receptors containing the hyperekplexia mutation alpha1-(K276E), expressed in Xenopus oocytes. J. Physiol. (London) 507, 25-40.
45. Lloyd, S.E., Pearce, S.H., Fisher, S.E., Steinmeyer, K., Schwappach, B., Schelnman, S.J., Harding, B., Bolino, A., Devoto, M., Goodyer, P., Rigden, S.P., Wrong, O., Jentsch, T.J., Craig, I.W. & Thakker, R.V. (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379, 445-449.
46. + channel exhibiting novel molecular mechanisms of long QT syndrome. FEBS Lett. 423, 5-9.
47. McCarthy, T.V., Quane, K.A. & Lynch, P.J. (2000) Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum. Mut. 15, 410-417.
48. Milone, M., Wang, H.L., Ohno, K., Fukudome, T., Pruitt, J.N., Bren, N., Sine, S.M. & Engel, A.G. (1997) Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J. Neurosci. 17, 5651-5665.
49. Mitrovic, N., George, A.L., Jr, Lerche, H., Wagner, S., Fahlke, C. & Lehmann-Horn, F. (1995) Different effects on gating of three myotonia-causing mutations in the inactivation gate of the human muscle sodium channel. J. Physiol. (London) 487, 107-114.
50. + current in paramyotonia congenita muscle. Brain 122, 1085-1092.
51. Monnier, N., Procaccio, V., Stieglitz, P. & Lunardi, J. (1997) Malignant-hyperthermia susceptibility is associated with a mutation of the alpha-1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Gen. 60, 1316-1325.
52. Moorhouse, A.J., Jacques, P., Barry, P.H. & Schofield, P.R. (1999) The startle disease mutation Q266H, in the second transmembrane domain of the human glycine receptor, impairs channel gating. Mol. Pharmacol. 55, 386-395.
53. 2+ channel expressed in Xenopus laevis oocytes. J. Physiol. (London) 520, 321-336.
54. Moslehi, R., Langlois, S., Yam, I. & Friedman, J.M. (1998) Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree. Am. J. Med. Gen. 76, 21-27.
55. Nakajima, T., Furukawa, T., Hirano, Y., Tanaka, T., Sakurada, H., Takahashi, T., Nagai, R., Itoh, T., Katayama, Y., Nakamura, Y. & Hiraoka, M. (1999) Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2. Cardiovasc. Res. 44, 283-293.
56. Neyroud, N., Tesson, F., Denjoy, I., Leibovici, M., Donger, C., Barhanin, J., Faure, S., Gary, F., Coumel, P., Petit, C., Schwartz, K. & Guicheney, P. (1997) A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nature Gen. 15, 186-189.
57. Nomura, H., Turco, A.E., Pei, Y., Kalaydjieva, L., Schiavello, T., Weremowicz, S., Ji, W., Morton, C.C., Meisler, M., Reeders, S.T. & Zhou, J. (1998) Identification of PKDL, a novel polycystic kidney disease 2-like gene whose murine homologue is deleted in mice with kidney and retinal defects. J. Biol. Chem. 273, 25967-25973.
58. Ohno, K., Hutchinson, D.O., Milone, M., Brengman, J.M., Bouzat, C., Sine, S.M. & Engel, A.G. (1995) Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc. Natl. Acad. Sci. U.S.A. 92, 758-762.
59. Ohno, K., Wang, H.L., Milone, M., Bren, N., Brengman, J.M., Nakano, S., Quiram, P., Pruitt, J.N., Sine, S.M. & Engel, A.G. (1996) Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron 17, 157-170.
60. 2+ channel gene CACNL1A4. Cell 87, 543-552.
61. Perry, E.K., Morris, C.M., Court, J.A., Cheng, A., Fairbairn, A.F., McKeith, I.G., Irving, D., Brown, A. & Perry, R.H. (1995) Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology. Neuroscience 64, 385-395.
62. Priori, S.G., Schwartz, P.J., Napolitano, C., Bianchi, L., Dennis, A., De Fusco, M., Brown, A.M. & Casari, G. (1998) A recessive variant of the Romano-Ward long-QT syndrome? Circulation 97, 2420-2425.
63. Pusch, M., Steinmeyer, K., Koch, M.C. & Jentsch, T.J. (1995) Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel. Neuron 15, 1455-1463.
64. Rajendra, S., Lynch, J.W., Pierce, K.D., French, C.R., Barry, P.H. & Schofield, P.R. (1994) Startle disease mutations reduce the agonist sensitivity of the human inhibitory glycine receptor. J. Biol. Chem. 269, 18739-18742.
65. + channel fast and slow inactivation in paramyotonia congenita mutants expressed in Xenopus laevis oocytes. J. Physiol. (London) 499, 589-600.
66. Rinne, J.O., Myllykyla, T., Lonnberg, P. & Marjamaki, P. (1991) A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res. 547, 167-170.
67. + channel. Am. J. Physiol 276, 259-266.
68. Rook, M.B., Alshinawi, C.B., Groenewegen, W.A., van Gelder, I.C., van Ginneken, A.C., Jongsma, H.J., Mannens, M.M. & Wilde, A.A. (1999) Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc. Res. 44, 507-517.
69. Saul, B., Kuner, T., Sobetzko, D., Brune, W., Hanefeld, F., Meinck, H.M. & Becker, C.M. (1999) Novel GLRA1 missense mutation (P250T) in dominant hyperekplexia defines an intracellular determinant of glycine receptor channel gating. J. Neurosci. 19, 869-877.
70. Schmitt, N., Schwarz, M., Peretz, A., Abitbol, I., Attali, B. & Pongs, O. (2000) A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J. 19, 332-340.
71. Seibert, F.S., Jia, Y., Mathews, C.J., Hanrahan, J.W., Riordan, J.R., Loo, T.W. & Clarke, D.M. (1997) Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel. Biochemistry 36, 11966-11974.
72. Shalaby, F.Y., Levesque, P.C., Yang, W.P., Little, W.A., Conder, M.L., Jenkins-West, T. & Blanar, M.A. (1997) Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. Circulation 96, 1733-1736.
73. Sharma, N., Crane, A., Gonzalez, G., Bryan, J. & Aguilar-Bryan, L. (2000) Familial hyperinsulinism and pancreatic beta-cell ATP-sensitive potassium channels. Kidney Int. 57, 803-808.
74. - channels with altered pore properties. Nature 362, 160-164.
75. Simon, D.B., Bindra, R.S., Mansfield, T.A., Nelson-Williams, C., Mendonca, E., Stone, R., Schurman, S., Nayir, A., Alpay, H., Bakkaloglu, A., Rodriguez-Soriano, J., Morales, J.M., Sanjad, S.A., Taylor, C.M., Pilz, D., Brem, A., Trachtman, H., Griswold, W., Richard, G.A., John, E. & Lifton, R.P. (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nature Gen. 17, 171-178.
76. Sine, S.M., Ohno, K., Bouzat, C., Auerbach, A., Milone, M., Pruitt, J.N. & Engel, A.G. (1995) Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron 15, 229-239.
77. Splawski, I., Tristani-Firouzi, M., Lehmann, M.H., Sanguinetti, M.C. & Keating, M.T. (1997) Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nature Gen. 17, 338-340.
78. Spranger, M., Spranger, S., Schwab, S., Benninger, C. & Dichgans, M. (1999) Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. Eur. Neurol. 41, 150-152.
79. Steinlein, O.K., Mulley, J.C., Propping, P., Wallace, R.H., Phillips, H.A., Sutherland, G.R., Scheffer, I.E. & Berkovic, S.F. (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Gen. 11, 201-203.
80. Takahashi, M.P. & Cannon, S.C. (1999) Enhanced slow inactivation by V445M: A sodium channel mutation associated with myotonia. Biophys. J. 76, 861-868.
81. Takamori, M., Komai, K. & Iwasa, K. (2000) Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome. Am. J. Med. Sci. 319, 204-208.
82. Thomas, P., Ye, Y. & Lightner, E. (1996) Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy. Hum. Mol. Gen. 5, 1809-1812.
83. Tsui, L.-C. (1992) The spectrum of cystic fibrosis mutations. Trends Gen. 8, 392-398.
84. Vankeerberghen, A., Wei, L., Jaspers, M., Cassiman, J.J., Nilius, B. & Cuppens, H. (1998) Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator. Hum. Mol. Gen. 7, 1761-1769.
85. Wagner, S., Lerche, H., Mitrovic, N., Heine, R., George, A.L. & Lehmann-Horn, F. (1997) A novel sodium channel mutation causing a hyperkalemic paralytic and paramyotonic syndrome with variable clinical expressivity. Neurology 49, 1018-1025.
86. +-channel betal subunit gene SCN1B. Nature Gen. 19, 366-370.
87. + channel. Circulation 99, 3165-3171.
88. Weiland, S., Witzemann, V., Villarroel, A., Propping, P. & Steinlein, O. (1996) An amino acid exchange in the second transmembrane segment of a neuronal nicotinic receptor causes partial epilepsy by altering its desensitization kinetics. FEBS Lett. 398, 91-96.
89. Wollnik, B., Kubisch, C., Steinmeyer, K. & Pusch, M. (1997) Identification of functionally important regions of the muscular chloride channel CIC-1 by analysis of recessive and dominant myotonic mutations. Hum. Mol. Gen. 6, 805-811.
90. Zhang, J., Bendahhou, S., Sanguinetti, M.C. & Ptacek, L.J. (2000) Functional consequences of chloride channel gene (CLCN1) mutations causing myotonia congenita. Neurology 54, 937-942.
91. Zhou, Z., Gong, Q., Epstein, M.L. & January, C.T. (1998) HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J. Biol. Chem. 273, 21061-21066.